BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19124392)

  • 1. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.
    Grundy SM
    Nat Rev Drug Discov; 2006 Apr; 5(4):295-309. PubMed ID: 16582875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome: screening, diagnosis, and management.
    Miller EL; Mitchell A
    J Midwifery Womens Health; 2006; 51(3):141-51. PubMed ID: 16647666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention.
    Towfighi A; Ovbiagele B
    Cerebrovasc Dis; 2008; 26(2):106-12. PubMed ID: 18560212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep and the metabolic syndrome.
    Wolk R; Somers VK
    Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome: are we at risk?
    Paudel B
    Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of metabolic syndrome in morbidly obese children and adolescents.
    Quintos JB; Castells S
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():564-70. PubMed ID: 17237744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiology patient page. The metabolic syndrome.
    Lennie TA
    Circulation; 2006 Oct; 114(15):e528-9. PubMed ID: 17030691
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
    Ganne S; Arora S; Karam J; McFarlane SI
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):201-11. PubMed ID: 17338665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome: a gathering challenge in a time of abundance.
    Bricker LA; Greydanus DE
    Adolesc Med State Art Rev; 2008 Dec; 19(3):475-97, ix. PubMed ID: 19227387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
    Krentz AJ; Clough G; Byrne CD
    J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The metabolic syndrome].
    Internist (Berl); 1995 May; 36(5 Suppl Metabolisc):1-12. PubMed ID: 9403089
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxazosin in metabolically complicated hypertension.
    Dell'Omo G; Penno G; Del Prato S; Pedrinelli R
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1027-35. PubMed ID: 18035918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women and the metabolic syndrome: an overview of its peculiarities.
    Allende-Vigo MZ
    P R Health Sci J; 2008 Sep; 27(3):190-5. PubMed ID: 18782961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.